• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青少年皮肌炎的血管病变

The Vasculopathy of Juvenile Dermatomyositis.

作者信息

Papadopoulou Charalampia, McCann Liza J

机构信息

Infection, Inflammation, and Rheumatology Section, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.

Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom.

出版信息

Front Pediatr. 2018 Oct 9;6:284. doi: 10.3389/fped.2018.00284. eCollection 2018.

DOI:10.3389/fped.2018.00284
PMID:30356795
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6189418/
Abstract

Juvenile dermatomyositis (JDM) is a rare autoimmune disease mainly characterized by muscle and skin involvement. Vasculopathy is considered central to the pathogenesis of the disease. The exact nature of vasculopathy is not yet understood but it is a complex process with both an inflammatory and a non-inflammatory, occlusive component. Impaired function of JDM vasculature includes immune complex deposition, altered expression of cell adhesion molecules predominantly inducing Th17 cell infiltration, and endothelial cell dysfunction. Development of vasculopathy is associated with the severe extra-muscular manifestations of JDM, such as gastrointestinal and cardiac manifestations, interstitial lung disease, ulcerative skin disease or development of calcinosis, and portends a poor prognosis. Correlation of histopathological findings, autoantibodies, and extensive diagnostic workup represent key elements to the early detection of vasculopathic features and early aggressive treatment. Monitoring of vasculopathy remains challenging due to the lack of non-invasive biomarkers. Current treatment approaches provide variable benefit, but better understanding of the essential pathogenic mechanisms should help lead to improved outcomes. Whilst acknowledging that evidence is limited, this review aims to describe the vasculopathy of JDM in the context of pathophysiology, clinical features, and treatment of disease.

摘要

幼年皮肌炎(JDM)是一种罕见的自身免疫性疾病,主要特征为肌肉和皮肤受累。血管病变被认为是该疾病发病机制的核心。血管病变的确切性质尚不清楚,但它是一个复杂的过程,既有炎症成分,也有非炎症性的闭塞成分。JDM血管功能受损包括免疫复合物沉积、细胞黏附分子表达改变,主要诱导Th17细胞浸润,以及内皮细胞功能障碍。血管病变的发展与JDM严重的肌肉外表现相关,如胃肠道和心脏表现、间质性肺病、溃疡性皮肤病或钙质沉着的发生,并预示预后不良。组织病理学发现、自身抗体以及广泛诊断检查之间的相关性是早期发现血管病变特征和早期积极治疗的关键要素。由于缺乏非侵入性生物标志物,对血管病变的监测仍然具有挑战性。目前的治疗方法疗效各异,但更好地理解基本致病机制应有助于改善治疗结果。尽管认识到证据有限,但本综述旨在从疾病的病理生理学、临床特征和治疗方面描述JDM的血管病变。

相似文献

1
The Vasculopathy of Juvenile Dermatomyositis.青少年皮肌炎的血管病变
Front Pediatr. 2018 Oct 9;6:284. doi: 10.3389/fped.2018.00284. eCollection 2018.
2
Systemic and Tissue Inflammation in Juvenile Dermatomyositis: From Pathogenesis to the Quest for Monitoring Tools.幼年特发性皮肌炎的系统性和组织炎症:从发病机制到探索监测工具。
Front Immunol. 2018 Dec 18;9:2951. doi: 10.3389/fimmu.2018.02951. eCollection 2018.
3
Juvenile dermatomyositis: new insights and new treatment strategies.幼年型皮肌炎:新的认识和新的治疗策略。
Ther Adv Musculoskelet Dis. 2012 Feb;4(1):41-50. doi: 10.1177/1759720X11424460.
4
Association of anti-TPM4 autoantibodies with vasculopathic cutaneous manifestations in juvenile dermatomyositis.抗 TPM4 自身抗体与儿童皮肌炎血管病变皮肤表现的相关性。
Rheumatology (Oxford). 2023 Nov 2;62(11):3757-3762. doi: 10.1093/rheumatology/kead203.
5
Vasculopathy-related clinical and pathological features are associated with severe juvenile dermatomyositis.血管病变相关的临床和病理特征与严重的青少年皮肌炎相关。
Rheumatology (Oxford). 2016 Mar;55(3):470-9. doi: 10.1093/rheumatology/kev359. Epub 2015 Sep 30.
6
Juvenile Dermatomyositis With Rare Cutaneous Manifestation: Generalised Hypertrichosis.幼年型皮肌炎伴罕见皮肤表现:广泛性多毛症。
J Pak Med Assoc. 2023 Jul;73(7):1539-1541. doi: 10.47391/JPMA.7453.
7
Cardiovascular Abnormalities in Juvenile Dermatomyositis: A Scoping Review for the Clinical Rheumatologists.青少年皮肌炎的心血管异常:临床风湿病学家的范围综述
Front Med (Lausanne). 2022 Jun 24;9:827539. doi: 10.3389/fmed.2022.827539. eCollection 2022.
8
Juvenile dermatomyositis.幼年型皮肌炎。
Curr Rheumatol Rep. 2011 Jun;13(3):216-24. doi: 10.1007/s11926-011-0167-9.
9
Treatment of Calcinosis in Juvenile Dermatomyositis.治疗幼年皮肌炎的钙质沉着症。
Curr Rheumatol Rep. 2021 Feb 8;23(2):13. doi: 10.1007/s11926-020-00974-9.
10
Juvenile Dermatomyositis.青少年皮肌炎
J Rheum Dis. 2022 Jan 1;29(1):14-21. doi: 10.4078/jrd.2022.29.1.14.

引用本文的文献

1
CD68 + macrophage infiltrations in muscle tissue of juvenile dermatomyositis associated with the course of the disease, not with the severity.CD68+巨噬细胞浸润于幼年皮肌炎的肌肉组织中,与疾病进程相关,而非与疾病严重程度相关。
Clin Rheumatol. 2025 Sep;44(9):3629-3638. doi: 10.1007/s10067-025-07601-x. Epub 2025 Jul 28.
2
CAR T cell therapy for children with rheumatic disease: the time is now.用于治疗风湿性疾病患儿的嵌合抗原受体T细胞疗法:时机已至。
Nat Rev Rheumatol. 2025 Jul 2. doi: 10.1038/s41584-025-01272-3.
3
Physical Growth Dynamics of Children With Juvenile Dermatomyositis.

本文引用的文献

1
Juvenile dermatomyositis: Latest advances.幼年特发性关节炎:最新进展。
Best Pract Res Clin Rheumatol. 2017 Aug;31(4):535-557. doi: 10.1016/j.berh.2017.12.003. Epub 2018 Jan 10.
2
Cardiovascular and cerebrovascular comorbidities of juvenile dermatomyositis in US children: an analysis of the National Inpatient Sample.美国儿童青少年皮肌炎的心血管和脑血管合并症:国家住院患者样本分析。
Rheumatology (Oxford). 2018 Apr 1;57(4):694-702. doi: 10.1093/rheumatology/kex465.
3
Multiple target autoantigens on endothelial cells identified in juvenile dermatomyositis using proteomics.
青少年皮肌炎患儿的身体生长动态
Cureus. 2025 Feb 28;17(2):e79861. doi: 10.7759/cureus.79861. eCollection 2025 Feb.
4
Monozygotic twins discordant for juvenile dermatomyositis: clinical, serological and gene expression studies.患幼年皮肌炎的单卵双胞胎:临床、血清学及基因表达研究
Pediatr Rheumatol Online J. 2025 Mar 26;23(1):32. doi: 10.1186/s12969-025-01082-7.
5
[Cutaneous ulceration in dermatomyositis : Case reports with positive anti-NXP-2/anti-TIF1-gamma antibody status].[皮肌炎中的皮肤溃疡:抗NXP-2/抗TIF1-γ抗体阳性状态的病例报告]
Dermatologie (Heidelb). 2025 Feb;76(2):97-100. doi: 10.1007/s00105-024-05462-0. Epub 2025 Jan 16.
6
The Role of Pyroptosis-Related Gene Signature and Immune Infiltration in Juvenile Dermatomyositis.焦亡相关基因特征及免疫浸润在幼年皮肌炎中的作用
Clin Cosmet Investig Dermatol. 2025 Jan 9;18:61-76. doi: 10.2147/CCID.S492340. eCollection 2025.
7
Anesthetic Challenges in Laparoscopic Surgery for a Child with Juvenile Dermatomyositis.青少年皮肌炎患儿腹腔镜手术的麻醉挑战
Cureus. 2024 Oct 8;16(10):e71056. doi: 10.7759/cureus.71056. eCollection 2024 Oct.
8
Unveiling Cardiac Involvement in Juvenile Dermatomyositis Through Speckle-Tracking Echocardiography.通过斑点追踪超声心动图揭示青少年皮肌炎的心脏受累。
Pediatr Cardiol. 2024 Jun;45(5):1007-1014. doi: 10.1007/s00246-024-03438-4. Epub 2024 Mar 28.
9
Local injection of infliximab into calcinosis lesions in patients with juvenile dermatomyositis (JDM): a clinical trial.局部注射英夫利昔单抗治疗幼年皮肌炎患者的钙质沉着症:一项临床试验。
Pediatr Rheumatol Online J. 2024 Jan 2;22(1):2. doi: 10.1186/s12969-023-00941-5.
10
The emerging role of growth differentiation factor 15 as a potential disease biomarker in juvenile dermatomyositis.生长分化因子15作为青少年皮肌炎潜在疾病生物标志物的新作用。
Rheumatology (Oxford). 2025 Feb 1;64(2):805-809. doi: 10.1093/rheumatology/kead654.
利用蛋白质组学技术在青少年皮肌炎中鉴定出内皮细胞上的多个自身抗原靶标。
Rheumatology (Oxford). 2018 Apr 1;57(4):671-676. doi: 10.1093/rheumatology/kex468.
4
Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling.边缘结构模型显示环磷酰胺治疗重症幼年皮肌炎的疗效和安全性。
Arthritis Rheumatol. 2018 May;70(5):785-793. doi: 10.1002/art.40418. Epub 2018 Mar 25.
5
Amyopathic Dermatomyositis Associated with Histopathological Findings of Organizing Pneumonia and Pulmonary Vasculitis.无肌病性皮肌炎伴机化性肺炎和肺血管炎的组织病理学表现。
Balkan Med J. 2017 Aug 4;34(4):374-377. doi: 10.4274/balkanmedj.2016.1061. Epub 2017 Apr 13.
6
Childhood Arthritis and Rheumatology Research Alliance consensus clinical treatment plans for juvenile dermatomyositis with skin predominant disease.儿童关节炎与风湿病研究联盟关于以皮肤为主型疾病的青少年皮肌炎的共识临床治疗方案
Pediatr Rheumatol Online J. 2017 Jan 11;15(1):1. doi: 10.1186/s12969-016-0134-0.
7
Childhood Arthritis and Rheumatology Research Alliance Consensus Clinical Treatment Plans for Juvenile Dermatomyositis with Persistent Skin Rash.儿童关节炎与风湿病研究联盟关于伴有持续性皮疹的青少年皮肌炎的共识临床治疗方案
J Rheumatol. 2017 Jan;44(1):110-116. doi: 10.3899/jrheum.160688. Epub 2016 Nov 1.
8
Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies.成人及青少年特发性炎性肌病的心脏受累情况。
RMD Open. 2016 Sep 27;2(2):e000291. doi: 10.1136/rmdopen-2016-000291. eCollection 2016.
9
Consensus-based recommendations for the management of juvenile dermatomyositis.基于共识的青少年皮肌炎管理建议。
Ann Rheum Dis. 2017 Feb;76(2):329-340. doi: 10.1136/annrheumdis-2016-209247. Epub 2016 Aug 11.
10
Muscle Biopsy Findings in Combination With Myositis-Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis.肌肉活检结果与肌炎特异性自身抗体联合有助于预测幼年皮肌炎的结局。
Arthritis Rheumatol. 2016 Nov;68(11):2806-2816. doi: 10.1002/art.39753. Epub 2016 Oct 9.